Trial Profile
Single Country Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis Patients Treated With BG00012
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Mar 2022
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary) ; Methylprednisolone
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms StarTec
- Sponsors Biogen
- 12 Oct 2018 Results presented at the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
- 02 Feb 2017 Status changed from active, no longer recruiting to completed.
- 22 Sep 2016 Planned End Date changed from 1 Feb 2017 to 1 Oct 2016.